Log in to save to my catalogue

The management of metastatic GIST: current standard and investigational therapeutics

The management of metastatic GIST: current standard and investigational therapeutics

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d62e2751f1f3486291c04b61fd8985f4

The management of metastatic GIST: current standard and investigational therapeutics

About this item

Full title

The management of metastatic GIST: current standard and investigational therapeutics

Publisher

England: BioMed Central Ltd

Journal title

Journal of hematology and oncology, 2021-01, Vol.14 (1), p.2-2, Article 2

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. The majority of GISTs harbor gain of function mutations in either KIT or PDGFRα. Determination of the GIST molecular subtype upon diagnosis is important because this information informs therapeutic decisions in both the adjuvant and metastatic...

Alternative Titles

Full title

The management of metastatic GIST: current standard and investigational therapeutics

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d62e2751f1f3486291c04b61fd8985f4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d62e2751f1f3486291c04b61fd8985f4

Other Identifiers

ISSN

1756-8722

E-ISSN

1756-8722

DOI

10.1186/s13045-020-01026-6

How to access this item